Showing results (111-120 of 323) with videos related to

Sort By:
Pageof 33
Arthritis and Rheumatism|June 30, 2005
Lack of support for the presence of an osteoarthritis susceptibility locus on chromosome 6pGary K Meenagh, David McGibbon, James Nixon, et al.
Pain|November 23, 2021
Efficacy of nonpharmacological interventions for individual features of fibromyalgia: a systematic review and meta-analysis of randomised controlled trialsBurak Kundakci, Jaspreet Kaur, Siew Li Goh, et al.
Rheumatology (Oxford, England)|May 26, 2018
Rheumatoid arthritis and excess mortality: down but not out. A primary care cohort study using data from Clinical Practice Research DatalinkAbhishek Abhishek, Georgina Nakafero, Chang-Fu Kuo, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 3, 2007
An assessment of the discriminative ability of the EQ-5Dindex, SF-6D, and EQ VAS, using sociodemographic factors and clinical conditionsGarry R Barton, Tracey H Sach, Michael Doherty, et al.
Arthritis Care & Research|September 3, 2016
Early Clinical Features in Systemic Lupus Erythematosus: Can They Be Used to Achieve Earlier Diagnosis? A Risk Prediction ModelFrances Rees, Michael Doherty, Peter Lanyon, et al.
Annals of the Rheumatic Diseases|June 13, 2014
Dipeptidyl peptidase-4 inhibitors in type 2 diabetes may reduce the risk of autoimmune diseases: a population-based cohort studySeoyoung C Kim, Sebastian Schneeweiss, Robert J Glynn, et al.
Arthritis Research & Therapy|October 13, 2016
Familial risk of systemic sclerosis and co-aggregation of autoimmune diseases in affected familiesChang-Fu Kuo, Shue-Fen Luo, Kuang-Hui Yu, et al.
BMJ (Clinical Research Ed.)|August 20, 2009
Lifestyle interventions for knee pain in overweight and obese adults aged > or = 45: economic evaluation of randomised controlled trialGarry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Medical Care|July 9, 2009
Comparing cost-utility estimates: does the choice of EQ-5D or SF-6D matter?Tracey H Sach, Garry R Barton, Claire Jenkinson, et al.
Health and Quality of Life Outcomes|July 16, 2008
Do estimates of cost-utility based on the EQ-5D differ from those based on the mapping of utility scores?Garry R Barton, Tracey H Sach, Claire Jenkinson, et al.
Pageof 33